Workflow
WJP(301117)
icon
Search documents
佳缘科技(301117) - 独立董事2024年度述职报告(赵宇虹)
2025-04-23 13:10
佳缘科技股份有限公司 独立董事 2024 年度述职报告 (赵宇虹) 各位股东及股东代表: 本人赵宇虹作为佳缘科技股份有限公司(以下简称"公司")第三届董事会 独立董事、审计委员会委员(主任委员)、提名委员会委员(主任委员)、薪酬 与考核委员会委员(主任委员),在 2024 年度任职期间严格按照《中华人民共 和国公司法》《中华人民共和国证券法》《上市公司独立董事规则》《深圳证券 交易所创业板股票上市规则》等法律、法规和规范性文件以及《公司章程》《独 立董事工作制度》等规定和要求,本着维护公司利益和股东尤其是中小股东的权 益的原则,诚信、勤勉、尽责、独立履行职务,积极参与公司的各项事务,认真 审议董事会各项议案,客观、公正、独立地履行职责。现将 2024 年度工作情况 报告如下: 一、报告期内出席董事会和股东大会情况 2024 年度,公司共召开了 4 次董事会会议和 3 次股东大会会议,本人按时 出席了 4 次董事会、3 次股东大会,没有缺席或连续两次未亲自出席会议的情况。 本人出席会议情况如下: | | 本报告 | 现场出 | 以通讯 | 委托出 | 缺席 | 是否连续 | 出席股 | | --- | --- ...
佳缘科技(301117) - 董事会对独董独立性评估的专项意见
2025-04-23 13:10
佳缘科技股份有限公司 董事会关于独立董事独立性评估的专项意见 根据《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等要求,佳缘科技股份有限公司(以下简称"公司")董事会就公司在任独立董 事肖军、赵宇虹的独立性情况进行评估并出具如下专项意见: 经核查独立董事肖军、赵宇虹的任职经历以及签署的相关自查文件,上述人 员未在公司担任除独立董事以外的任何职务,也未在公司主要股东公司担任任何 职务,与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观 判断的关系。综上,公司独立董事符合《上市公司独立董事管理办法》《深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》中对独立 董事独立性的相关要求。 佳缘科技股份有限公司 董事会 2025 年 4 月 24 日 ...
佳缘科技:2024年报净利润0.11亿 同比增长320%
Tong Hua Shun Cai Bao· 2025-04-23 12:58
| 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 陈瑶 | 26.00 | 0.57 | 退出 | | 宝盈资源优选混合 | 25.68 | 0.56 | 退出 | 二、前10名无限售条件股东持股情况 前十大流通股东累计持有: 771.59万股,累计占流通股比: 16.83%,较上期变化: -182.38万股。 | 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 朱伟华 | 188.58 | 4.12 | 不变 | | 厦门鑫瑞集英创业投资合伙企业(有限合伙) | 180.00 | 3.93 | -180.00 | | 朱伟民 | 126.06 | 2.75 | 不变 | | 中信证券投资有限公司 | 92.29 | 2.01 | 不变 | | 洪子平 | 40.50 | 0.88 | 新进 | | 张晓彤 | 34.59 | 0.75 | 新进 | | 平安沪深300指数增强股票型养老金产 ...
佳缘科技(301117) - 2025 Q1 - 季度财报
2025-04-23 12:50
Financial Performance - The company's operating revenue for Q1 2025 was ¥22,117,341.59, representing a 35.66% increase compared to ¥16,303,006.10 in the same period last year[5] - The net loss attributable to shareholders was ¥14,409,054.51, an improvement of 8.83% from a loss of ¥15,805,349.87 in the previous year[5] - The company’s basic and diluted earnings per share were both -¥0.16, showing a 5.88% improvement from -¥0.17 in the previous year[5] - Net profit for the current period was ¥-15,019,204.03, compared to ¥-16,208,018.34 in the previous period, showing an improvement of approximately 7.3%[26] - Total operating costs amounted to ¥41,893,222.77, up from ¥37,646,335.81, indicating an increase of about 6.3%[25] Cash Flow and Liquidity - The net cash flow from operating activities was -¥81,523,823.15, a decline of 151.95% compared to -¥32,357,041.59 in the same period last year[5] - Operating cash inflow totaled $39,170,610.94, down 26.1% from $52,976,305.82 in the previous period[29] - Cash outflow from operating activities increased to $120,694,434.09, up 41.4% from $85,333,347.41 in the previous period[30] - Cash inflow from investment activities was $130,689,361.10, down 64.0% from $362,349,016.74 in the previous period[30] - The ending cash and cash equivalents balance was $336,132,675.98, down from $491,382,239.48 in the previous period[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,488,443,408.80, down 2.75% from ¥1,530,596,654.60 at the end of the previous year[5] - The company’s total liabilities decreased significantly, with other current liabilities dropping by 89.54% to ¥285,000.00 from ¥2,723,920.51[10] - Total liabilities decreased to ¥181,302,307.64 from ¥209,991,434.57, a reduction of approximately 13.8%[24] - The total equity attributable to shareholders was ¥1,301,641,476.92, down from ¥1,314,706,171.80, indicating a decrease of about 1.0%[24] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,613[15] - The total number of restricted shares held by major shareholders decreased to 35,513,381.0 shares, down from 46,444,756.0 shares, reflecting a reduction of approximately 23.5%[19] - The company’s major shareholder, Wang Jin, directly holds 37.68% of the company's shares, with an additional indirect holding of 0.12% through a partnership, totaling 37.80%[18] - The company has a significant shareholder relationship, with Wang Jin and Yin Mingjun collectively holding 37.97% of the shares[18] Operational Changes - The company completed the registration of changes in its business license, with the legal representative changed from Wang Jin to Zhu Weimin as of March 3, 2025[20] - The company reported a significant increase in accounts receivable financing, which rose by 968.27% to ¥13,374,074.58 from ¥1,251,932.91[10] - The company’s prepayments rose to CNY 13,664,074.86 from CNY 3,916,160.44, indicating an increase of approximately 249.5%[22] Government Support - The company received government subsidies amounting to ¥61,151.93, which are closely related to its regular business operations[6] Research and Development - Research and development expenses for the current period were ¥14,951,680.48, slightly up from ¥14,000,612.82, reflecting an increase of about 6.8%[26] Audit and Governance - The company did not undergo an audit for the first quarter report[31] - The board of directors meeting was held on April 24, 2025[32]
佳缘科技(301117) - 2024 Q4 - 年度财报
2025-04-23 12:50
Financial Performance - The company's revenue for 2024 reached ¥336,799,849.27, representing a 48.11% increase compared to ¥227,392,776.98 in 2023[19]. - The net profit attributable to shareholders for 2024 was ¥11,445,371.40, a significant turnaround from a loss of ¥5,352,891.52 in 2023, marking a 313.82% improvement[19]. - The basic earnings per share for 2024 increased to ¥0.12, compared to a loss of ¥0.06 per share in 2023, reflecting a 300.00% growth[19]. - The total assets of the company as of the end of 2024 amounted to ¥1,530,596,654.60, which is a 7.52% increase from ¥1,423,596,090.48 at the end of 2023[19]. - The company reported a cash flow from operating activities net amount of -¥50,830,933.56 for 2024, showing a slight improvement of 3.10% from -¥52,457,560.47 in 2023[19]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥3,303,725.63, a 120.29% increase from a loss of ¥16,280,503.83 in 2023[19]. - The weighted average return on equity for 2024 was 0.87%, recovering from -0.41% in 2023[19]. - The company received government subsidies amounting to ¥3,349,365.57 in 2024, which positively impacted its financial performance[25]. - The company achieved a revenue of CNY 336.80 million in 2024, representing a year-on-year growth of 48.11%[57]. - Net profit attributable to shareholders reached CNY 11.45 million, up 313.82% year-on-year, while the net profit after deducting non-recurring gains and losses increased by 120.29% to CNY 3.30 million[57]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 0.2 RMB per 10 shares to all shareholders, totaling approximately 18.45 million RMB based on 92,263,300 shares[5]. - The profit distribution proposal includes a capital reserve conversion of 4 additional shares for every 10 shares held by shareholders[5]. - The company will not distribute cash dividends for the fiscal year 2023, nor will it issue bonus shares or convert capital reserves into share capital[164]. - The proposed cash dividend for the fiscal year 2024 is set at 0.2 yuan per 10 shares, with a total expected cash dividend of 1,845,266 yuan[166]. - The company plans to increase its total share capital to 129,168,620 shares after a proposed capital reserve conversion of 4 shares for every 10 shares held[166]. Governance and Compliance - The report confirms that all board members attended the meeting to review the annual report, ensuring accountability for the report's accuracy[5]. - The financial report is guaranteed to be true, accurate, and complete by the company's responsible personnel, including the CEO and accounting head[5]. - The company has established a governance structure that ensures equal rights for all shareholders, particularly minority shareholders, and guarantees their participation in major decisions[125]. - The board of directors consists of 5 members, including 2 independent directors, meeting the legal requirements for board composition[126]. - The company has implemented a strategic committee, a compensation and assessment committee, an audit committee, and a nomination committee, with independent directors leading most of these committees[126]. - The company has not reported any instances of the controlling shareholder interfering with its decision-making or operations, maintaining an independent business structure[125]. - The company has a dedicated supervisory board with 3 members, ensuring compliance and oversight of major transactions and financial conditions[126]. - The company has disclosed its market expansion strategies and future product development plans during investor communications[121][122]. - The company has adhered to disclosure requirements related to cybersecurity business as per the Shenzhen Stock Exchange guidelines[62]. - The company has not provided any guarantees or loans to its controlling shareholders or their enterprises[130]. Market and Strategic Initiatives - The company is focused on expanding its market presence and enhancing its product offerings through new technologies and strategic initiatives[11]. - The company has engaged in strategic partnerships to enhance its technological capabilities and market reach[27]. - The company is actively expanding its market presence, particularly in the military and healthcare sectors, to enhance its competitive edge[58]. - The company is exploring acquisition opportunities to enhance its product offerings and market presence[7]. - The company aims to increase its market share in the healthcare informatization sector by leveraging growth opportunities in regional healthcare and emerging technology applications[33]. - The company plans to enhance market competitiveness through deeper business expansion, contributing to increased sales volume[67]. Research and Development - The company has established a robust technology R&D system, focusing on new product development in data security and information technology solutions[54]. - The company is investing $50 million in R&D for new technologies aimed at enhancing user experience[5]. - R&D investment amounted to ¥63,109,499.31 in 2024, representing 18.74% of operating revenue, a decrease from 27.88% in 2023[87]. - The company has completed several medical data management systems and plans to advance its medical + big data projects, including the development of version 3.0 of the electronic medical record system[113]. - The company is focusing on developing specialized chips based on network security coding applications, with two projects (SIP100 and SIP400) in the pipeline for research and production[113]. Employee and Talent Management - The company has established a comprehensive training system and annual training plans to enhance employee skills and career development[162]. - The company has implemented a mentorship program to enhance new employee integration and skill development, fostering a collaborative work environment[163]. - The company is implementing measures to reduce talent turnover and enhance talent management through improved incentive systems and performance evaluations[119]. - The company has committed to not laying off employees or reducing salaries, while actively recruiting talent to support business development[181]. - The company provides comprehensive welfare benefits to employees, including various types of insurance and paid leave[181]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and performance forecasts, indicating that these do not constitute binding commitments to investors[5]. - The management discussion section outlines potential risks in the company's future development, which investors are advised to pay attention to[5]. - The company is exposed to accounts receivable collection risks, particularly due to the complex payment approval processes of its main clients, which include government and military entities[118]. - The company anticipates order fluctuations due to changes in procurement policies or approval processes within the network information security industry[119]. Social Responsibility and Environmental Compliance - The company has actively engaged in social responsibility, adhering to laws and regulations while promoting green and low-carbon development[179]. - The company has no reported environmental penalties during the reporting period, indicating compliance with environmental regulations[179]. - The company actively participates in social responsibility and public welfare initiatives, promoting local economic development[181]. Shareholder Relations - The company conducted multiple investor relations activities throughout 2024, including on-site research and online communication, focusing on performance, product technology, and market conditions[121][122][123][124][125][126]. - The company has committed to maintaining stock price stability, with a plan to repurchase shares if the stock price falls below the audited net asset value per share for 20 consecutive trading days within three years post-IPO[190]. - The company will ensure that all related party transactions are disclosed and conducted at fair market prices, adhering to relevant laws and regulations[189]. - The company has pledged to avoid transferring profits through related party transactions and will seek to maintain transparency and fairness in all dealings[190].
佳缘科技:鑫瑞集英拟减持公司不超1.95%股份
人民财讯3月14日电,佳缘科技(301117)3月14日晚间公告,公司持股1.95%的特定股东厦门鑫瑞集英创 业投资合伙企业(有限合伙)(简称"鑫瑞集英")计划以大宗交易方式和/或集中竞价交易方式合计减 持公司股份不超过180万股(占公司总股本的1.95%)。 ...
佳缘科技(301117) - 关于特定股东减持股份预披露的公告
2025-03-14 13:48
证券代码:301117 证券简称:佳缘科技 公告编号:2025-019 佳缘科技股份有限公司 关于特定股东减持股份预披露的公告 厦门鑫瑞集英创业投资合伙企业(有限合伙)保证向本公司提供的信息内容真 实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示: (一)股东名称:厦门鑫瑞集英创业投资合伙企业(有限合伙) (二)股东持股数量、持股比例:截至本公告日,鑫瑞集英共持有公司股份 1,800,000 股,占公司股份总数的 1.95%。 二、本次减持计划的主要内容 (一)减持原因:股东资金需求; (二)股份来源:公司首次公开发行股票并上市前已发行股份; (三)拟减持数量和比例:计划减持公司股份的数量合计不超过 1,800,000 股,占公司总股本的 1.95%。鑫瑞集英已获得中国证券投资基金业协会备案。根 据《创投减持特别规定》及《创投减持实施细则》规定,截至公司首次公开发行 上市日,鑫瑞集英投资期限已满 36 个但不满 48 个月(投资公司时间为 2018 年 3 月 4 日),在任意连续 60 个自然日内通过集中竞价交易方式减持股份不 ...
佳缘科技(301117) - 关于公司完成工商变更登记并取得营业执照的公告
2025-03-12 10:36
证券代码:301117 证券简称:佳缘科技 公告编号:2025-018 佳缘科技股份有限公司 关于公司完成工商变更登记并取得营业执照的公告 营业期限:1994 年 08 月 30 日至长期 一、变更后的营业执照基本情况 名称:佳缘科技股份有限公司 统一社会信用代码:91510100209459605G 类型:股份有限公司(上市、自然人投资或控股) 法定代表人:朱伟民 注册资本:玖仟贰佰贰拾陆万叁仟叁佰元整 成立日期:1994 年 08 月 30 日 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 佳缘科技股份有限公司(以下简称"公司")于 2025 年 2 月 18 日、2025 年 3 月 3 日分别召开第三届董事会第二十四次会议、第三届监事会第二十三次会议、 2025 年第一次临时股东大会,审议并通过了《关于修订<公司章程>并办理工商 变更登记的议案》,详情请见公司刊登在巨潮资讯网(www.cninfo.com.cn)的 相关公告。 近日,公司办理完成相关内容的工商变更登记手续,并取得了成都市市场监 督管理局换发的《营业执照》,相关登记信息如下: 住所:成 ...
佳缘科技(301117) - 关于董事会、监事会完成换届选举及聘任高级管理人员、证券事务代表的公告
2025-03-03 12:30
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 佳缘科技股份有限公司(以下简称"公司")于2025年3月3日召开了2025年 第一次临时股东大会,审议通过了《关于董事会换届选举第四届董事会非独立董 事的议案》《关于董事会换届选举第四届董事会独立董事的议案》《关于监事会 换届选举第四届监事会非职工代表监事的议案》,选举产生了公司第四届董事会 非独立董事3名,第四届董事会独立董事2名,第四届监事会非职工代表监事2名。 公司于2025年2月12日召开了2025年第一次职工代表大会选举产生公司第四届监 事会职工代表监事1名。公司董事会、监事会换届选举工作已完成。 2025年3月3日,公司召开了第四届董事会第一次会议,审议通过了《关于选 举公司第四届董事会董事长的议案》《关于选举公司第四届董事会副董事长的议 案》《关于选举第四届董事会专门委员会委员的议案》《关于聘任公司高级管理 人员的议案》《关于聘任公司证券事务代表的议案》,选举产生了公司第四届董 事会董事长、副董事长,第四届董事会专门委员会委员,高级管理人员及证券事 务代表。同日公司召开了第四届监事会第一次会议,审议 ...
佳缘科技(301117) - 2025年第一次临时股东大会决议公告
2025-03-03 12:30
证券代码:301117 证券简称:佳缘科技 公告编号:2025-014 佳缘科技股份有限公司 2025年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 特别提示: 1、本次会议不存在否决议案的情形; 2、本次股东大会不涉及变更以往股东大会决议的情形。 一、会议召开和出席情况 (一)会议召开情况 1、会议召集人:佳缘科技股份有限公司(以下简称"公司")董事会 2、会议主持人:董事长王进女士 3、会议召开的合法、合规性:本次股东大会会议召开符合有关法律、行政 法规、部门规章、规范性文件和《公司章程》的相关规定。 4、会议召开的日期、时间: 现场会议召开日期、时间为:2025年3月3日(星期一)14:50 通过深圳证券交易所交易系统进行网络投票的具体时间为:2025年3月3日 的交易时间,即9:15—9:25 ,9:30—11:30和13:00—15:00。 通过深圳证券交易所互联网投票系统进行网络投票的具体时间为:2025年3 月3日9:15—15:00。 5、本次股东大会召开方式:本次股东大会采取现场投票、网络投票相结合 的方式。 6 ...